Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Lexicon Pharma Falls on Concerns Raised by Merck-Pfizer Diabetes Partnership
TheStreet.com
Monday, April 29, 2013 - 11:48am
tags:
Merck, Pfizer, Lexicon Pharmaceuticals, diabetes, ertugliflozin, LX4211
Forbes Earnings Preview: Merck
Forbes
Monday, April 29, 2013 - 11:47am
tags:
earnings, Merck
Bayer to buy birth-control devices maker for $1.1 billion
Yahoo/Reuters
Monday, April 29, 2013 - 11:41am
tags:
Bayer, M&A, Conceptus
The Biogen MS Pill: The 'Holy Mother' Of All Drug Launches?
Pharmalot
Monday, April 29, 2013 - 11:40am
tags:
Biogen Idec, Tecfidera, drug launches, MS, multiple sclerosis
Teva Pharmaceuticals Is A Bitter Pill To Swallow
Seeking Alpha
Monday, April 29, 2013 - 11:35am
tags:
Teva
The Compelling Science Behind Synergy
Seeking Alpha
Monday, April 29, 2013 - 11:33am
tags:
Synergy Pharmaceuticals, plecanatide, Ironwood, Linzess
Pfizer, Zoetis Reporting Q1 In Wake Of Bad News
Investors.com
Monday, April 29, 2013 - 11:32am
tags:
earnings, Pfizer, Zoetis
KCI Announces Global Rollout of Novel Skin Graft Harvesting Tool
CP Wire
Monday, April 29, 2013 - 11:30am
tags:
skin grafting, KCI, CelluTome
Biogen MS Pill’s Early Sales May Help It Beat Estimates
Bloomberg
Monday, April 29, 2013 - 10:52am
tags:
MS, multiple sclerosis, Biogen Idec, BG-12, Tecfidera
Impax, GSK end Parkinson's disease partnership
Reuters
Monday, April 29, 2013 - 10:50am
tags:
GSK, Impax Laboratories, Parkinson's Disease, Rytary
FDA rejects two Gilead HIV drugs as standalone products
Reuters
Monday, April 29, 2013 - 10:49am
tags:
FDA, HIV, Gilead, cobicistat, elvitegravir, Stribild
Merck, Pfizer to jointly develop diabetes drug
Reuters
Monday, April 29, 2013 - 10:48am
tags:
Merck, Pfizer, diabetes, ertugliflozin
Pfizer and 3 Dow Healthcare Stocks Driving Headlines This Week
Wall St. Cheat Sheet
Monday, April 29, 2013 - 10:47am
tags:
Pfizer, Merck, JNJ, Unitedhealthcare Group
Trounce the Market With This Diabetes Care Company
Motley Fool
Monday, April 29, 2013 - 10:46am
tags:
diabetes, Novo Nordisk
Gilead-Bristol Hepatitis C Drug Combo Cures All in Study
Bloomberg
Monday, April 29, 2013 - 10:26am
tags:
Gilead, Bristol-Myers Squibb, hepatitis C, declatasvir, sofosbuvir
Horizon Technology Finance Closes $2 Million Venture Loan Facility with New Haven Pharmaceuticals
PR Newswire
Sunday, April 28, 2013 - 12:42pm
tags:
New Haven Pharmaceuticals
Pfizer Presents Phase 3 Safety And Immunogenicity Data On Prevenar 13 In Adults Aged 18 To 49 Years
Yahoo/BusinessWire
Sunday, April 28, 2013 - 12:23pm
tags:
Pfizer, Prevenar, pneumococcal disease, vaccines
Abbott Is A Solid Long-Term Investment
Seeking Alpha
Sunday, April 28, 2013 - 12:22pm
tags:
Abbott Laboratories
AbbVie Earnings Call Nuggets: Growth Guidance and Drug Candidates
Wall Street Cheat Street
Sunday, April 28, 2013 - 12:21pm
tags:
AbbVie, earnings
High But Well-Managed Risk, This Company Is One To Watch Out For
Seeking Alpha
Sunday, April 28, 2013 - 12:14pm
tags:
BioTime

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.